Navigation Links
Imaging Tests Up Among Advanced Cancer Patients
Date:7/31/2012

TUESDAY, July 31 (HealthDay News) -- A new U.S. study finds that the use of diagnostic imaging tests in Medicare patients with advanced cancer has risen faster than among patients with early-stage cancer.

The costs of diagnostic imaging have increased more than the overall costs of cancer care, making diagnostic imaging the fastest-growing part of Medicare-reimbursed services, the researchers noted. Medicare is the U.S. government-funded health insurance program for people over 65 and certain other patients.

They added that cancer care costs are highest during the last year of life, but little is known about the use of high-cost imaging tests in cancer patients during their final year.

In this study, the researchers examined data on the use of CT, MRI, PET and nuclear medicine scans for Medicare patients with late-stage (stage 4) breast, colon, lung or prostate cancer between 1995 and 2006. Stage 4 cancer means the cancer has spread throughout the body.

The analysis revealed that most of the patients underwent imaging procedures during the course of their care, and that the use of imaging in late-stage cancer patients increased between 1995 and 2006.

The study was published July 30 in the Journal of the National Cancer Institute.

The increasing use of imaging in late-stage cancer patients may be due to a lack of guidelines in this area or the use of imaging to help doctors manage symptoms, detect disease progression and assess the effects of treatment, said Dr. Yue-Yung Hu and colleagues at the Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the University of Wisconsin.

While imaging often leads to appropriate measures to ease dying patients' suffering, it can also distract them from focusing on achievable end-of-life goals, cause them to spend more of their remaining time in medical care settings, and provoke anxiety, the researchers said.

Determining the most appropriate care for patients with late-stage cancer is complex, Drs. Robin Yabroff and Joan Warren, of the Health Services and Economics Branch at the U.S. National Cancer Institute, noted in an accompanying editorial.

"Physicians tend to overestimate survival for terminally ill cancer patients, which may influence their treatment and related imaging recommendations," they wrote in a journal news release. "Development of practice guidelines for advanced imaging in patients with stage IV disease, with explicit statements about the state of evidence will be critical, particularly for care outside of the window surrounding patient diagnosis."

More information

The American Cancer Society offers advice for cancer patients nearing the end of life.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, July 30, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
2. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
3. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
4. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
5. Study examines necessity of additional imaging in PET/CT oncologic reports
6. Fox Chase researchers find no disparities in imaging before breast cancer surgery
7. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
8. Mount Sinai is first in New York state to perform new Alzheimers imaging test in clinical setting
9. Imaging agents predict breast cancer response to endocrine therapy
10. Noninvasive imaging technique may help kids with heart transplants
11. Fighting obesity with thermal imaging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Imaging Tests Up Among Advanced Cancer Patients 
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving multi-billion ... head shops –can’t help but be heartened by the industry’s current surge. But another ... described as “skunk smell.” At last they can simply, safely and effectively end ...
(Date:4/25/2017)... ... ... There is no better place in South Florida to undergo two common heart ... of Consumer Reports focused on heart health. , The magazine gave Memorial ... bypass and aortic valve replacement procedures. , Consumer Reports rated Memorial’s Cardiac ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American ... pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in a ...
(Date:4/24/2017)... ... 2017 , ... As part of the nationwide Days of Remembrance effort led ... Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced ... trip to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: